These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3266113

  • 1. Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
    Esteves K.
    Bull World Health Organ; 1988; 66(6):739-46. PubMed ID: 3266113
    [Abstract] [Full Text] [Related]

  • 2. The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group.
    WHO Consultative Group.
    Bull World Health Organ; 1982; 60(2):231-42. PubMed ID: 6980734
    [Abstract] [Full Text] [Related]

  • 3. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J.
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [Abstract] [Full Text] [Related]

  • 4. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE, Abed Y, Marcus O, Gerichter CB, Melnick JL.
    Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G, Linkins RW, Eames MA, Wood DJ, Campbell PJ, Ankers E, Deniel M, Kabbaj A, Magrath DI, Minor PD.
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [Abstract] [Full Text] [Related]

  • 6. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK, Strebel PM, de Quadros CA, Olivé JM.
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [Abstract] [Full Text] [Related]

  • 7. The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry.
    Bull World Health Organ; 1976; 53(4):319-31. PubMed ID: 1086727
    [Abstract] [Full Text] [Related]

  • 8. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R, Arras-Reiter C, Arens ER, Quast U, Maass G.
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [Abstract] [Full Text] [Related]

  • 9. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.
    Kohler KA, Banerjee K, Gary Hlady W, Andrus JK, Sutter RW.
    Bull World Health Organ; 2002; 80(3):210-6. PubMed ID: 11984607
    [Abstract] [Full Text] [Related]

  • 10. Vaccination against poliomyelitis in economically underdeveloped countries.
    Sabin AB.
    Bull World Health Organ; 1980; 58(1):141-57. PubMed ID: 6966544
    [Abstract] [Full Text] [Related]

  • 11. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L, Birkhead G, Guerra F, Helms C, Hinman A, Katz S, LeBaron CW, Modlin J, Murphy TV, National Vaccine Advisory Committee-Advisory Committee on Immunization Practices Joint Working Group, Centers for Disease Control and Prevention.
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [Abstract] [Full Text] [Related]

  • 12. [Worldwide eradication of poliomyelitis].
    Rasch G, Schreier E, Kiehl W, Kurth R.
    Wien Klin Wochenschr; 2001 Oct 30; 113(20-21):839-45. PubMed ID: 11732120
    [Abstract] [Full Text] [Related]

  • 13. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ.
    Bull World Health Organ; 2004 Jan 30; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [Abstract] [Full Text] [Related]

  • 14. Poliomyelitis surveillance and vaccine efficacy in Bombay, 1982-87.
    Kim-Farley RJ, Dave KH, Sokhey J, Mandke VB.
    Bull World Health Organ; 1989 Jan 30; 67(6):663-7. PubMed ID: 2633881
    [Abstract] [Full Text] [Related]

  • 15. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO, Feldman EV, Yermalovich MA, Protas II, Titov LP.
    Cent Eur J Public Health; 2003 Dec 30; 11(4):213-8. PubMed ID: 14768785
    [Abstract] [Full Text] [Related]

  • 16. Progress toward poliomyelitis eradication--India, December 1995 and January 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1996 May 10; 45(18):370-3. PubMed ID: 8606686
    [Abstract] [Full Text] [Related]

  • 17. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R, Dhole TN.
    J Med Virol; 2008 Aug 10; 80(8):1477-88. PubMed ID: 18551602
    [Abstract] [Full Text] [Related]

  • 18. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
    Strebel PM, Ion-Nedelcu N, Baughman AL, Sutter RW, Cochi SL.
    N Engl J Med; 1995 Feb 23; 332(8):500-6. PubMed ID: 7830731
    [Abstract] [Full Text] [Related]

  • 19. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC, Modlin JF.
    Pediatrics; 2006 Aug 23; 118(2):611-8. PubMed ID: 16882814
    [Abstract] [Full Text] [Related]

  • 20. Vaccine control of poliomyelitis in the 1980s.
    Sabin AB.
    Yale J Biol Med; 1982 Aug 23; 55(3-4):383-9. PubMed ID: 7180028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.